您的当前位置:首页 > 行业数据 > UBT251针对各项适应症的国内临床进展
图片属性
图片格式:PNG 图片大小:124KB 图片尺寸:2315*514
同报告图片
 / 4
UBT251针对各项适应症的国内临床进展_第1页
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
UBT251针对各项适应症的国内临床进展_第2页
UBT251针对各项适应症的国内临床进展_第3页
UBT251针对各项适应症的国内临床进展_第4页
UBT251针对各项适应症的国内临床进展_第5页
所属报告: 联邦制药(3933.HK)-港股公司研究报告:UBT251海外授权彰显研发成果创新管线打开成长天花板-250801(30页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠